Integrated Filing — IndAS



General information about company

Scrip Code 544476
NSE Symbol JSLL
MSEI Symbol NOTLISTED
ISIN INE0J5801029
Name of company JEENA SIKHO LIFECARE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 07-08-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 04-08-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment Trading of Ayurvedic Medicines and providing Ayurvedic Therapies
Start date and time of board meeting 07-08-2026   16:30:00
End date and time of board meeting 07-08-2026   16:42:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 22,440.48 22,440.48
Other income 1,401.51 1,401.51
Total income 23,841.99 23,841.99
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 2,703.05 2,703.05
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (136.20) (136.20)
(d) Employee benefit expense 4,417.79 4,417.79
(e) Finance costs 347.19 347.19
(f) Depreciation, depletion and amortisation expense 1,532.78 1,532.78
(f) Other Expenses
1 Other Expenses 6,243.81 6,243.81
Total other expenses 6,243.81 6,243.81
Total expenses 15,108.42 15,108.42
3 Total profit before exceptional items and tax 8,733.57 8,733.57
4 Exceptional items 0.00 0.00
5 Total profit before tax 8,733.57 8,733.57
6 Tax expense
7 Current tax 2,137.61 2,137.61
8 Deferred tax 26.78 26.78
9 Total tax expenses 2,164.39 2,164.39
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 6,569.18 6,569.18
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 6,569.18 6,569.18
17 Other comprehensive income net of taxes 47.21 47.21
18 Total Comprehensive Income for the period 6,616.39 6,616.39
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 2,486.01 2,486.01
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 5.28 5.28
Diluted earnings (loss) per share from continuing operations 5.28 5.28
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 5.28 5.28
Diluted earnings (loss) per share from continuing and discontinued operations 5.28 5.28
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Remark: All the Notes to the Unaudited Financial Results have already been disclosed as part of the PDF of the Outcome of the Board Meeting filed with the Stock Exchanges. For the purpose of Standalone XBRL filing, only Note No. 4 is being reproduced below, as the Standalone XBRL reflects a Single Segment whereas the Consolidated XBRL reflects Multiple Segments: Clarification: Segment information is disclosed only in the consolidated financial results in accordance with Ind AS 108, as the operating segments are monitored at the group level. Accordingly, no separate segment information is presented in the standalone financial results. 4. As per Ind AS 108 operating segment is a component of the Group that engages in business activities whose operating results are regularly reviewed by the Group's Chief Operating Decision Maker ('CODM)' to make decisions about resources to be allocated to the segment and assess its performance; and for which discrete financial information is available. Accordingly, The Group has identified the following operating segments: a) Ayurvedic Products and Medicines b) Ayurvedic Healthcare Services c) Others- significantly comprising royalty income, revenue share of income from diagnostic services, The CODM does not review assets and liabilities for each operating segment separately, hence segment information relating to the total assets and liabilities has not been furnished. In accordance with Ind AS 108 Operating Segments, the Company has opted to present segment information along with the consolidated financial results of the Group.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss (47.21) (47.21)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 47.21 47.21